The Tetracycline-Controlled Transactivator (Tet-On/Off) System in β-Cells Reduces Insulin Expression and Secretion in...

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• Controllable genetic manipulation is crucial for cell biology research.
• Challenges in beta-cell research include transgene silencing and off-target effects.

Purpose of the Study:

• To investigate if a Tetracycline (Tet)-Off system with a beta-cell-specific promoter could improve genetic manipulation in beta cells.
• To assess the impact of Tet-On/Tet-Off systems on beta-cell function and insulin regulation.

Main Methods:

• Utilized a Tet-Off system with mouse insulin promoter (MIP)-driven expression of tetracycline operon (TetO)-Cre in mice.
• Evaluated tissue-specific gene recombination, beta-cell architecture, glucose-stimulated insulin secretion (in vitro and in vivo), and glucose homeostasis.

Main Results:

• Expression of tetracycline-controlled transactivators (tTA, rtTA) in beta cells significantly reduced Insulin gene expression and insulin content.
• Pancreatic insulin levels and insulin secretion were decreased in mice with tTA transgenes, irrespective of Cre or doxycycline.
• Beta-cell function was impaired by the mere presence of the transactivator transgene.

Conclusions:

• The presence of tetracycline-controlled transactivator transgenes in beta cells negatively impacts insulin production and secretion.
• Existing Tet-On and Tet-Off systems present significant challenges for reliable genetic manipulation in beta cells.
• Emphasizes the need for rigorous controls when employing Tet-On/Tet-Off systems in beta-cell research.